Long before stars lit up the sky, the universe was a hot, dense place where simple chemistry quietly set the stage for everything to come. Scientists have now recreated the first molecule ever to form, helium hydride, and discovered it played a much bigger role in the birth of stars than we thought. Using a special ultra-cold lab setup, they mimicked conditions from over 13 billion years ago and found that this ancient molecule helped cool the universe just enough for stars to ignite. Their findings could rewrite part of the story about how the cosmos evolved from darkness to light.

About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To better understand why some tumors resist chemotherapy and identify better ways to treat those cancers, researchers at Baylor College of Medicine have conducted a detailed molecular analysis of MIBC tumors. The results, published in Cell Reports Medicine, offer potential new ways to identify which patients will benefit from chemotherapy and reveal possible new treatment strategies.

“One of our goals was to identify molecular markers in patient tumors that would help us predict which patients were most likely to benefit from chemotherapy and which ones might not,” said first co-author, Dr. Matthew V. Holt, director of the Lester and Sue Smith Breast Center Proteomics Laboratory at Baylor.

The researchers studied 60 MIBC tumor samples using a comprehensive multi-omics approach which included genomics (sequencing the genes of the tumor), transcriptomics (analyzing which genes are turned on or off), proteomics (the proteins produced by the tumor) and phosphoproteins (proteins with chemical tags that control their activity).

Please find under this blog the latest updates on exciting news happening every day in the world of Materials Science and Materials Chemistry research and development (with a special emphasis on the Computational aspects of these research fields), via our diverse selection of news articles! Many thanks for your interest and support, Dr. Gabriele Mogni Email contact: [email protected] Website: www.qscomputing.com

Message transfer from brain cell to brain cell is key to information processing, learning and forming memories. The bubbles, synaptic vesicles, are housed within the synapse — the connection point where brain cells communicate. In typical synapses within the brains of mammals, 300 synaptic vesicles are clustered together in the intersection between any two brain cells, but only a few of these vesicles are used for such message transfer, researchers say. Pinpointing how a synapse knows which vesicles to use has long been a target of research by those who study the biology and chemistry of thought.

In an effort to better understand the operation of these synaptic vesicles, the team designed a study that first focused on endocytosis, a process in which brain cells recycle synaptic vesicles after they are used for neuronal communication.

Already aware of intersectin’s general role in endocytosis and neuronal communication, the scientists genetically engineered mice to lack the gene that codes for intersectin. However, and somewhat to their surprise, the lead says removing the protein did not appear to halt endocytosis in brain cells.

The research team refocused their experiments, taking a closer look at the synaptic vesicles themselves.

Using a high-resolution fluorescence microscope to observe where intersectin is in a synapse, the researchers found it in between vesicles that are used for neuronal communication and those that are not, as if they are physically separating the two.

To further understand the role of intersectin at this location, they used an electron microscope to visualize synaptic vesicles in action across one billionth of a meter. In all the nerve cells from mice lacking this protein, the scientists say synaptic vesicles close to the membrane were absent from the release zone of the synapse, the place where the bubbles would discharge to nearby neurons.

“This suggested that intersectin regulates release, rather than recycling, of these vesicles at this location of the synapse,” says the author.

CHAMPAIGN-URBANA, Ill. (WCIA) — The U.S. National Science Foundation has awarded a University of Illinois lab $15 million. The money will support the development of AI tools, to help scientists quickly and efficiently synthesize molecules for medicine, energy, industry and more.

The money will be going to the Molecule Maker Lab Institute (MMLI) — which is based on the U of I’s campus, in partnership between Pennsylvania State University and the Georgia Institute of Technology. U of I chemical and biomolecular engineering professor Huimin Zhao directs the lab.

Zhao said functional molecules like drugs chemicals are important in today’s society, but the process of discovering new molecules is slow and expensive. He believes AI can change that.

Researchers at Kumamoto University and Nagoya University have developed a new class of two-dimensional (2D) metal-organic frameworks (MOFs) using triptycene-based molecules, marking a breakthrough in the quest to understand and enhance the physical properties of these promising materials. The work is published in the Journal of the American Chemical Society.

In recent years, 3D printing glass optics has gained massive attention in industry and academia since glass could be an ideal material to make optical elements, including the lens. However, the limitation of materials and printing methods has prevented 3D printing glass optics progress. Therefore, we have developed a novel printing strategy for germanate glass printing instead of pure silica. Moreover, compared with traditional multi-component quartz glass, germanate glass has unmatched advantages for its mid-infrared (MIR) transparency and outstanding visible light imaging performance. Furthermore, compared with non-oxide glass (fluoride glass and chalcogenide glass), germanate glass has much better mechanical, physical, and chemical properties and a high refractive index.

In a provocative study published in Nature Communications late last year, the neuroscientist Nikolay Kukushkin and his mentor Thomas J. Carew at New York University showed that human kidney cells growing in a dish can “remember” patterns of chemical signals when they’re presented at regularly spaced intervals — a memory phenomenon common to all animals, but unseen outside the nervous system until now. Kukushkin is part of a small but enthusiastic cohort of researchers studying “aneural,” or brainless, forms of memory. What does a cell know of itself? So far, their research suggests that the answer to McClintock’s question might be: much more than you think.

Brainless Learning

The prevailing wisdom in neuroscience has long been that memory and learning are consequences of “synaptic plasticity” in the brain. The connections between clusters of neurons simultaneously active during an experience strengthen into networks that remain active even after the experience has passed, perpetuating it as a memory. This phenomenon, expressed by the adage “Neurons that fire together, wire together,” has shaped our understanding of memory for the better part of a century. But if solitary nonneural cells can also remember and learn, then networks of neurons can’t be the whole story.

A team from the Max-Planck-Institut für Kohlenforschung, Hokkaido University, and Osaka University has discovered that subtle differences in molecular structure can have a major impact on the performance of mRNA-based drugs. Their findings, published in the Journal of the American Chemical Society, open the door to the development of safer and more effective vaccines and therapies.

To deliver therapeutic nucleic acids like mRNA into cells, scientists rely on lipid nanoparticles (LNPs)—tiny, fat-based carriers that protect fragile genetic material, enabling it to survive in the body and reach target cells. A key component of these LNPs are ionizable lipids, which help mRNA enter cells and then release it effectively. One such lipid, ALC-315, was notably used in the Pfizer/BioNTech COVID-19 vaccine, a medical breakthrough that played a critical role in controlling the global pandemic.

Pacific Northwest National Laboratory draws on its distinguishing strengths in chemistry, Earth sciences, biology and data science to advance scientific knowledge and address challenges in energy resiliency and national security. Founded in 1965, PNNL is operated by Battelle and supported by the Office of Science of the U.S. Department of Energy. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit the DOE Office of Science website. For more information about PNNL, visit PNNL’s News Center. Follow us on X, Facebook, LinkedIn and Instagram.